These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
64 related articles for article (PubMed ID: 7654058)
1. Multiple sclerosis: are HLA class I molecules involved in disease pathogenesis? Martin R; McFarland HF Ann Neurol; 1995 Aug; 38(2):137-9. PubMed ID: 7654058 [No Abstract] [Full Text] [Related]
2. Existence of MHC class I-restricted alloreactive CD4+ T cells reacting with peptide transporter-deficient cells. Kobayashi H; Kimura S; Aoki N; Sato K; Celis E; Katagiri M Immunogenetics; 2001 Oct; 53(8):626-33. PubMed ID: 11797095 [TBL] [Abstract][Full Text] [Related]
3. [MHC class I deficiency]. Morio T Ryoikibetsu Shokogun Shirizu; 2000; (32):15-7. PubMed ID: 11212671 [No Abstract] [Full Text] [Related]
4. Major histocompatibility complex class I-restricted alloreactive CD4+ T cells. Boyle LH; Goodall JC; Gaston JS Immunology; 2004 May; 112(1):54-63. PubMed ID: 15096184 [TBL] [Abstract][Full Text] [Related]
5. P-glycoprotein plays an insignificant role in the presentation of antigenic peptides to CD8+ T cells. Russ G; Ramachandra M; Hrycyna CA; Gottesman MM; Pastan I; Bennink JR; Yewdell JW Cancer Res; 1998 Oct; 58(20):4688-93. PubMed ID: 9788623 [TBL] [Abstract][Full Text] [Related]
6. Tapping into tumours. Elliott T Nat Genet; 1996 Jun; 13(2):139-40. PubMed ID: 8640213 [No Abstract] [Full Text] [Related]
7. TAP-independent selection of CD8+ intestinal intraepithelial lymphocytes. Sydora BC; Brossay L; Hagenbaugh A; Kronenberg M; Cheroutre H J Immunol; 1996 Jun; 156(11):4209-16. PubMed ID: 8666789 [TBL] [Abstract][Full Text] [Related]
8. HLA class I: friend and foe of multiple sclerosis. Martin R Nat Med; 2008 Nov; 14(11):1150-1. PubMed ID: 18989277 [No Abstract] [Full Text] [Related]
9. Tap-1 and Tap-2 gene therapy selectively restores conformationally dependent HLA Class I expression in type I diabetic cells. Wang F; Li X; Annis B; Faustman DL Hum Gene Ther; 1995 Aug; 6(8):1005-17. PubMed ID: 7578413 [TBL] [Abstract][Full Text] [Related]
10. Transporter associated with antigen processing. Elliott T Adv Immunol; 1997; 65():47-109. PubMed ID: 9238508 [No Abstract] [Full Text] [Related]
11. MHC class I antigen processing and presenting machinery: organization, function, and defects in tumor cells. Leone P; Shin EC; Perosa F; Vacca A; Dammacco F; Racanelli V J Natl Cancer Inst; 2013 Aug; 105(16):1172-87. PubMed ID: 23852952 [TBL] [Abstract][Full Text] [Related]
12. TAP-independent MHC class I peptide antigen presentation to alloreactive CTL is enhanced by target cell incubation at subphysiologic temperatures. Shi Y; Smith KD; Lutz CT J Immunol; 1998 May; 160(9):4305-12. PubMed ID: 9574533 [TBL] [Abstract][Full Text] [Related]
13. Reduced membrane major histocompatibility complex class I density and stability in a subset of human renal cell carcinomas with low TAP and LMP expression. Seliger B; Höhne A; Knuth A; Bernhard H; Ehring B; Tampé R; Huber C Clin Cancer Res; 1996 Aug; 2(8):1427-33. PubMed ID: 9816317 [TBL] [Abstract][Full Text] [Related]
14. Stage-dependent reactivity of thymocytes to self-peptide--MHC complexes. Leng Q; Ge Q; Nguyen T; Eisen HN; Chen J Proc Natl Acad Sci U S A; 2007 Mar; 104(12):5038-43. PubMed ID: 17360333 [TBL] [Abstract][Full Text] [Related]
15. Expression of transporters associated with antigen processing and human leucocyte antigen class I in malignant melanoma and its association with prognostic factors. Tao J; Li Y; Liu YQ; Li L; Liu J; Shen X; Shen GX; Tu YT Br J Dermatol; 2008 Jan; 158(1):88-94. PubMed ID: 17999701 [TBL] [Abstract][Full Text] [Related]
16. Defects in the human leukocyte antigen class I antigen processing machinery in head and neck squamous cell carcinoma: association with clinical outcome. Meissner M; Reichert TE; Kunkel M; Gooding W; Whiteside TL; Ferrone S; Seliger B Clin Cancer Res; 2005 Apr; 11(7):2552-60. PubMed ID: 15814633 [TBL] [Abstract][Full Text] [Related]
17. Major histocompatibility complex-encoded ABC transporters and rat class I peptide motifs. Powis SJ; Young LL; Barker PJ; Richardson L; Howard JC; Butcher GW Transplant Proc; 1993 Oct; 25(5):2752-3. PubMed ID: 8212225 [No Abstract] [Full Text] [Related]
18. Restoration of the expression of transports associated with antigen processing in human malignant melanoma increases tumor-specific immunity. Tao J; Li Y; Liu YQ; Wang L; Yang J; Dong J; Wu Y; Shen GX; Tu YT J Invest Dermatol; 2008 Aug; 128(8):1991-6. PubMed ID: 18385764 [TBL] [Abstract][Full Text] [Related]
19. Enhancing major histocompatibility complex class I antigen presentation by targeting antigen to centrosomes. Hung CF; Cheng WF; He L; Ling M; Juang J; Lin CT; Wu TC Cancer Res; 2003 May; 63(10):2393-8. PubMed ID: 12750257 [TBL] [Abstract][Full Text] [Related]
20. Antigen processing and presentation by human trophoblast-derived cell lines. Gobin SJ; Wilson L; Keijsers V; Van den Elsen PJ J Immunol; 1997 Apr; 158(8):3587-92. PubMed ID: 9103419 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]